SOC TELEMED, INC.

Inactive Instrument

Analyst Reco. SOC Telemed, Inc.

Equities

HCCO

US78472F1012

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Credit Suisse Lifts SOC Telemed's PT to $3 from $2 After News of Take-Private Deal with Patient Square Capital; Maintains Neutral Rating	07/02/22	MT
Benchmark Downgrades SOC Telemed to Hold From Buy	04/02/22	MT
RBC Capital Downgrades SOC Telemed to Sector Perform From Outperform, Lowers Price Target to $3 From $6	03/02/22	MT
Baird Downgrades SOC Telemed to Neutral from Outperform, Adjusts Price Target to $3 from $4	03/02/22	MT
Credit Suisse Downgrades SOC Telemed to Neutral from Outperform, Says Among Potential M&A Targets; Lowers PT to $2 from $6	07/01/22	MT
SOC TELEMED : Benchmark Adjusts SOC Telemed's Price Target to $7 From $10, Reiterates Buy Rating	13/08/21	MT
SOC TELEMED : Credit Suisse Lowers SOC Telemed's Price Target to $8.50 From $11 After 2021 Guidance Cut, Keeps Outperform Rating	13/08/21	MT
SOC TELEMED : RBC Cuts Price Target on SOC Telemed to $6 From $10, Citing Reduced Revenue Outlook; Outperform Rating Maintained	13/08/21	MT
SOC TELEMED : Baird Starts SOC Telemed at Outperform with $7.50 Price Target	28/05/21	MT
SOC TELEMED : Credit Suisse Starts SOC Telemed at Outperform With $11 Price Target	16/02/21	MT
SOC TELEMED : RBC Capital Starts SOC Telemed at Outperform With $10 Price Target	28/01/21	MT
SOC TELEMED : Benchmark Capital Initiates Coverage on SOC Telemed With Buy Rating, $12 Price Target	15/01/21	MT
SOC TELEMED : BTIG Starts SOC Telemed at Buy with $12 Price Target	07/01/21	MT
SOC TELEMED : Baird Starts SOC Telemed at Outperform With $12 Price Target	01/12/20	MT
SOC TELEMED : William Blair Initiates Coverage on SOC Telemed With Outperform Rating	25/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer